Euro election - what does it mean for the "pharmaceutical package"?
This article was originally published in Scrip
It may be low on its radar at the moment, but among the dossiers that the new European Parliament will face later this year is the "pharmaceutical package" of legislation on information to patients, pharmacovigilance and counterfeit medicines.
You may also be interested in...
The EU’s new health commissioner, Stella Kyriakides, has outlined the commission’s plans for dealing with medicines access issues in the EU member states. They include completing the review of the EU pediatric and orphan legislation and developing a new strategic plan to tackle shortages and affordability problems next year.
AstraZeneca’s Lynparza can now be used on the Scottish National Health Service for newly diagnosed advanced ovarian cancer.
As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks.